Target Name: KRT16P3
NCBI ID: G644945
Other Name(s): keratin 16 pseudogene 3 | Keratin 16 pseudogene 3 | KERSMCR

KRT16P3: A Potential Drug Target and Biomarker

Keratin 16 (K16) is a gene that encodes a portion of the keratin protein that makes up the hair and nails. In individuals with genetic disorders such as alopecia areata, a common condition that causes the loss of hair, the K16 gene is often mutated or dysfunctional. As a result, researchers have been investigating the potential role of K16 in the development and progression of these conditions.

One promising lead is the KRT16P3 gene, which has been shown to be mutated in individuals with alopecia areata. The KRT16P3 gene encodes a pseudogene that has not been found in individuals with alopecia areata. However, studies have shown that the KRT16P3 gene is expressed in hair follicles, and that it is highly expressed in individuals with alopecia areata.

Furthermore, research has also shown that the KRT16P3 gene is involved in the development and progression of various skin diseases, including photoaging, dermatitis, and cancer. This suggests that K16 may be a promising biomarker for these conditions and may also be a drug target.

One potential mechanism by which K16 may be involved in the development and progression of skin diseases is through its role in cell signaling. The K16 gene has been shown to encode a protein that is involved in cell signaling pathways, including the TGF-β pathway. This pathway is known to play a role in the development and progression of various skin diseases, including photoaging, dermatitis, and cancer.

In addition, the K16 gene has also been shown to encode a protein that is involved in the regulation of cellular growth and differentiation. This suggests that K16 may be involved in the regulation of skin cell growth and may be a potential drug target for treatments aimed at reducing skin cell proliferation.

Another potential mechanism by which K16 may be involved in the development and progression of skin diseases is through its role in inflammation. The K16 gene has been shown to encode a protein that is involved in the regulation of inflammatory responses. This suggests that K16 may be involved in the regulation of skin inflammation and may be a potential drug target for treatments aimed at reducing inflammation.

In conclusion, the KRT16P3 gene has been shown to be mutated in individuals with alopecia areata and has been involved in the development and progression of various skin diseases. Further research is needed to determine the role of K16 in these conditions and to explore its potential as a drug target. By investigating the functions of K16 and its potential as a drug target, researchers may be able to develop new treatments for alopecia areata and other skin diseases.

Protein Name: Keratin 16 Pseudogene 3

More Common Targets

KRT16P6 | KRT17 | KRT17P1 | KRT17P2 | KRT17P3 | KRT17P5 | KRT17P7 | KRT18 | KRT18P1 | KRT18P12 | KRT18P13 | KRT18P16 | KRT18P17 | KRT18P19 | KRT18P22 | KRT18P23 | KRT18P24 | KRT18P27 | KRT18P28 | KRT18P29 | KRT18P31 | KRT18P33 | KRT18P34 | KRT18P4 | KRT18P40 | KRT18P41 | KRT18P42 | KRT18P44 | KRT18P48 | KRT18P49 | KRT18P5 | KRT18P50 | KRT18P51 | KRT18P55 | KRT18P59 | KRT18P6 | KRT18P62 | KRT19 | KRT19P2 | KRT19P3 | KRT2 | KRT20 | KRT222 | KRT23 | KRT24 | KRT25 | KRT26 | KRT27 | KRT28 | KRT3 | KRT31 | KRT32 | KRT33A | KRT33B | KRT34 | KRT35 | KRT36 | KRT37 | KRT38 | KRT39 | KRT4 | KRT40 | KRT42P | KRT5 | KRT6A | KRT6B | KRT6C | KRT7 | KRT7-AS | KRT71 | KRT72 | KRT73 | KRT73-AS1 | KRT74 | KRT75 | KRT76 | KRT77 | KRT78 | KRT79 | KRT8 | KRT80 | KRT81 | KRT82 | KRT83 | KRT84 | KRT85 | KRT86 | KRT87P | KRT89P | KRT8P10 | KRT8P11 | KRT8P12 | KRT8P14 | KRT8P16 | KRT8P17 | KRT8P18 | KRT8P22 | KRT8P23 | KRT8P25 | KRT8P26